Opportunity ID: 356428

General Information

Document Type: Grants Notice
Funding Opportunity Number: HT942524GBMRPHDA
Funding Opportunity Title: DOD Glioblastoma, Hypothesis Development Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 13
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 16, 2024
Last Updated Date: Sep 16, 2024
Original Closing Date for Applications: Nov 20, 2024
Current Closing Date for Applications: Nov 20, 2024
Archive Date: Dec 20, 2024
Estimated Total Program Funding: $4,640,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The FY24 GBMRP Hypothesis Development Award supports the exploration of highly innovative, untested, exploratory, high-risk/potentially high-gain concepts, theories, paradigms, and/or methods that address an important problem relevant to one or more of the FY24 GBMRP Hypothesis Development Award Focus Areas.

This award is designed to provide investigators the opportunity to pursue serendipitous observations that may reveal entirely new avenues for investigation. Results of studies conducted through this award may provide the scientific premise upon which a new hypothesis can be based or initial proof-of-principle of an innovative hypothesis, laying the groundwork for future glioblastoma-focused research projects.

The GBMRP encourages applications from early-career investigators and applications that include meaningful and productive collaborations between investigators. PIs with little to no previous glioblastoma experience are encouraged to collaborate with experienced glioblastoma researchers and/or clinicians.

Key Aspects of the Hypothesis Development Award:

Presentation of preliminary data is inconsistent with the intent of this award mechanism and is therefore strongly discouraged. However, proposals should be based on sound scientific rationale that is established through logical reasoning and critical review and analysis of the literature.

Innovation: It is the responsibility of the Principal Investigators (PIs) to clearly and explicitly articulate how the proposed research project meets the exploratory intent of this mechanism and is innovative in the field of glioblastoma research.

Impact: The PI(s) should articulate the short- and long-term impact of the proposed research on both the glioblastoma research field as well as the patient community. The anticipated impact must be significant and move beyond an incremental advancement.

Partnering Principal Investigator Option: The FY24 GBMRP Hypothesis Development Award includes an option for more than one PI. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. The other PI will be identified as the Partnering PI. This funding opportunity allows one Partnering PI. Both PIs should contribute significantly to the development and execution of the proposed research project. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). Each award will be subject to separate reporting, regulatory, and administrative requirements. For individual submission requirements for the Initiating and Partnering PI, refer to Section II.D.2, Content and Form of the Application Submission.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date

Folder 356428 Full Announcement-FY24 GBMRP HDA -> HT942524GBMRPHDA.pdf

Folder 356428 Full Announcement-FY24 GBMRP HDA -> FY24 GBMRP PA Reference Table.pdf

Packages

Agency Contact Information: CDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00287913 Sep 16, 2024 Nov 20, 2024 View

Package 1

Mandatory forms

356428 RR_SF424_5_0-5.0.pdf

356428 AttachmentForm_1_2-1.2.pdf

356428 RR_PersonalData_1_2-1.2.pdf

356428 RR_KeyPersonExpanded_4_0-4.0.pdf

356428 RR_Budget_3_0-3.0.pdf

356428 PerformanceSite_4_0-4.0.pdf

Optional forms

356428 RR_SubawardBudget30_3_0-3.0.pdf

2025-07-13T08:33:58-05:00

Share This Post, Choose Your Platform!

About the Author: